The Gabrail Pharmacology Phase 1 Research Center
Canton, Ohio 44718
1 studies enrolling now · 2 studies all time
What they study most
Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma, Advanced Solid Tumor, CCNE1 Amplification, Endometrial Cancer, Endometrial Diseases, Endometrial Neoplasms, Gastric Cancer, Hormone Receptor Negative Breast Carcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Metastatic Endometrial Cancer
Studies at this site
- XTX301 in Patients With Advanced Solid Tumors — Recruiting now
- A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors — Stopped early